NCT00118521

Brief Summary

Musculoskeletal conditions account for the third leading cause of health systems expenditure in Australia. Patellofemoral pain syndrome or pain about the knee cap is such a condition often treated in primary care. Both the individual and community are affected by this condition with an estimated 1 in 4 sufferers having problems and pain up to 20 years after first being afflicted. Importantly, it interferes with activities such as walking, jogging, gym classes and aerobics, which are often prescribed to prevent serious conditions of the heart, diabetes and obesity. Hence, it negatively impacts the health and well being of our nation. Two popular treatment options that are commonly prescribed for the management of patellofemoral pain syndrome are physiotherapy and foot orthotics. To date, there is some evidence supporting physiotherapy, especially current best practice methods, such as a combined program of therapeutic exercise, manual therapy and kneecap taping. There is a lack of evidence for the use of orthotics in treating patellofemoral pain syndrome. This project will conduct a randomised clinical trial to evaluate the relative benefits of orthotics as the sole treatment of patellofemoral pain syndrome and also when combined with physiotherapy. Factors associated with predicting the results of orthotic therapy will be studied to see if there are any tests that a health care practitioner can perform to provide information early on in a consultation regarding possible treatment outcomes. A cost-benefit analysis will also be conducted to calculate the relative economic merits of the treatments. A tangible outcome of this project will be the development of clinical guidelines for the most effective method of treating patellofemoral pain syndrome in primary health care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 2004

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 1, 2005

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 11, 2005

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2007

Completed
Last Updated

December 19, 2013

Status Verified

September 1, 2006

Enrollment Period

3.1 years

First QC Date

July 1, 2005

Last Update Submit

December 18, 2013

Conditions

Keywords

Anterior Knee Pain

Outcome Measures

Primary Outcomes (5)

  • Worst and Usual Pain Visual Analogue Scale

  • Functional Index Questionnaire

  • Anterior Knee Pain Scale

  • Patient Perceived Treatment Effect score

  • Perceived Global Effect 5 Point Scale

Secondary Outcomes (8)

  • Physical activity level in previous week

  • Step up, step down and squat tests

  • Lower Extremity Functional Scale

  • McGill Pain Questionnaire

  • SF-36 Health Survey

  • +3 more secondary outcomes

Interventions

PhysiotherapyPROCEDURE

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of patellofemoral pain syndrome (non traumatic origin) of at least 6 weeks duration
  • Pain with at least 2 of the following activities: stair walking, jogging/running, squatting, hopping/jumping, kneeling or prolonged sitting

You may not qualify if:

  • Concomitant injury or pathology of other knee joint structures, eg. meniscal, ligamentous etc.
  • Pain in or referred from the lumbar spine and hip
  • History of knee fractures, patellar dislocation/subluxation with a positive apprehension test
  • Prior physiotherapy treatment (including patellar taping) within the past 12 months
  • History of allergic reaction to adhesive tape
  • Current or previous foot orthotic use
  • Any condition of the foot that precludes orthotic therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Musculoskeletal Pain & Injury Research Unit, Division of Physiotherapy, The University of Queensland

Brisbane, Queensland, 4072, Australia

Location

Related Publications (4)

  • Collins NJ, Bierma-Zeinstra SM, Crossley KM, van Linschoten RL, Vicenzino B, van Middelkoop M. Prognostic factors for patellofemoral pain: a multicentre observational analysis. Br J Sports Med. 2013 Mar;47(4):227-33. doi: 10.1136/bjsports-2012-091696. Epub 2012 Dec 13.

  • Collins N, Crossley K, Beller E, Darnell R, McPoil T, Vicenzino B. Foot orthoses and physiotherapy in the treatment of patellofemoral pain syndrome: randomised clinical trial. Br J Sports Med. 2009 Mar;43(3):169-71. doi: 10.1136/bmj.a1735.

  • Collins N, Crossley K, Beller E, Darnell R, McPoil T, Vicenzino B. Foot orthoses and physiotherapy in the treatment of patellofemoral pain syndrome: randomised clinical trial. BMJ. 2008 Oct 24;337:a1735. doi: 10.1136/bmj.a1735.

  • Vicenzino B, Collins N, Crossley K, Beller E, Darnell R, McPoil T. Foot orthoses and physiotherapy in the treatment of patellofemoral pain syndrome: a randomised clinical trial. BMC Musculoskelet Disord. 2008 Feb 27;9:27. doi: 10.1186/1471-2474-9-27.

MeSH Terms

Conditions

Patellofemoral Pain Syndrome

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • Bill Vicenzino, PhD

    The University of Queensland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 1, 2005

First Posted

July 11, 2005

Study Start

May 1, 2004

Primary Completion

June 1, 2007

Study Completion

June 1, 2007

Last Updated

December 19, 2013

Record last verified: 2006-09

Locations